Found "AI": 1,091 results
Cost-utility analysis of 10- and 13- valent pneumococcal conjugate vaccines in Thailand
A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m
A research development of the system for screening of refractive errors and providing spectacles among pre-primary and primary school children in Thailand
Refractive error is a main cause of visual impairment and blindness around the world. Active screening to identify children with uncorrected refractive error and treating them throught the provision of spectacles is recommend in many countries. However, it is not clear what the best screening stratergy is. Therefore, this study focus on development
Cost-utility analysis of dasatinib and nilotinib for chronic myeloid leukemia patients who fail to respond to first-line treatment with imatinib in Thailand
Imatinib, the first tyrosine kinase inhibitor (TKI) has been used widely as a first-line treatment for newly diagnosed CML patients. Approximately 20-30% of CML patients are resistant or intolerant to the drug, and half of these cases are due to a gene mutation in the ABL domain. Recently, second generation TKIs have emerged, such as dasatinib and
Pursuing evidence-based policy in the health sector: The case of iodine supplementation for pregnant women in Thailand.
This project aims to provide policy makers evidences for regulating an appropriate iodine supplement for pregnant women in Thailand. Due to the concern of low IQ of Thai children, there is an agreement among stakeholders that it should start promote sufficient iodine intake since gestation period. This study comprised of systematic literature revie
Testing the combination of mobile health interventions for smoking cessation services uptake and smoking cessation: a factorial randomized trial in Thailand
Aim and objectives: This research aims to improve uptake of the Thailand National Quitline (TNQ) smoking cessation service and smoking cessation rates among Thai smokers. The objective of this study is to test whether text messages improves uptake of TNQ smoking cessation service and smoking cessation rates and to test which combination of text me
Cost-utility analysis of seasonal influenza vaccine among school children in Thailand
Objective: This study aims to assess the cost-utility of providing either trivalent live-attenuated influenza vaccine (LAIV) or trivalent inactivated influenza vaccine (TIV) to school-aged children to prevent seasonal influenza. Methods: A deterministic age-structured dynamic transmission model was constructed and used to evaluate economic conse
Adolescent Pregnancy Thailand 2013
โครงการประเมิน เทคโนโลยีและนโยบายด้านสุขภาพ กระทรวงสาธารณสุข ได้ทบทวน เอกสารทางวิชาการ รวมทั้งรายงานและบทความการศึกษาวิจ
Online Trainings and Webinars
Given the impact of COVID-19, HITAP and partner organisation are committing to continue translating knowledge pieces and technical trainings collaboration in the virtual approach. Such virtual sessions refer to webinars engaged with guest lectureres in the fields, and modelling trainings by HITAP and partners. This initiative has been largely welco
Development of reference case for economic evaluation on precision medicine for health insurance reimbursement in Thailand
The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve
Strengthen Capacity for Infectious Diseases Modelling in Thailand and Supporting the Use of Evidence to Respond to Pandemics Across the Asian Region and LMICs
Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions. The
10 / Page